SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-001567
Filing Date
2014-05-15
Accepted
2014-05-15 17:01:29
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 587771
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 20310
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 20605
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 10060
  Complete submission text file 0001493152-14-001567.txt   3707071

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE immy-20131231.xml EX-101.INS 455040
6 XBRL SCHEMA FILE immy-20131231.xsd EX-101.SCH 41999
7 XBRL CALCULATION FILE immy-20131231_cal.xml EX-101.CAL 43407
8 XBRL DEFINITION FILE immy-20131231_def.xml EX-101.DEF 116057
9 XBRL LABEL FILE immy-20131231_lab.xml EX-101.LAB 311168
10 XBRL PRESENTATION FILE immy-20131231_pre.xml EX-101.PRE 191991
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 14848591
SIC: 2834 Pharmaceutical Preparations